1-15 of 188
The Risk Equation: Combining uACR and eGFR for CV Prediction
Conversations in CV Risk AssessmentThe Risk Equation: Combining uACR and eGFR for CV Prediction
Matthew Sorrentino, MD
Ashish Verma, MBBS
Albuminuria: An Overlooked Red Flag in Cardiovascular Risk
Conversations in CV Risk AssessmentAlbuminuria: An Overlooked Red Flag in Cardiovascular Risk
Matthew Sorrentino, MD
Ashish Verma, MBBS
Hidden High Risk: When BP Control Isn’t Enough in Hypertension
Conversations in CV Risk AssessmentHidden High Risk: When BP Control Isn’t Enough in Hypertension
Gates B. Colbert, MD
Michael E. Hall, MD
Clyde W. Yancy, MD
Understanding Residual Cardiovascular Risk in CKD and T2D
Diabetes DiscourseUnderstanding Residual Cardiovascular Risk in CKD and T2D
John W. Ostrominski, MD, MPH
Efficacy and Safety of Finerenone in Patients With Non-Diabetic CKD: Insight From FIND-CKD
NephrologyEfficacy and Safety of Finerenone in Patients With Non-Diabetic CKD: Insight From FIND-CKD
prof. Hiddo Heerspink
Finerenone Efficacy and Safety in Patients With CKD Regardless of Diabetes Status: Insights From the INFINITY Dataset
NephrologyFinerenone Efficacy and Safety in Patients With CKD Regardless of Diabetes Status: Insights From the INFINITY Dataset
Rajiv Agarwal, MBBS, MD, FASN, BRCU
- advertisement
Finerenone Subgroup Analyses in Patients With Glomerulonephritis
NephrologyFinerenone Subgroup Analyses in Patients With Glomerulonephritis
Brendon Neuen, MBBS, PhD
A Multi-Pillar Approach to Cardio-Renal Risk Reduction
Heart MattersA Multi-Pillar Approach to Cardio-Renal Risk Reduction
Brian P. McDonough, MD, FAAFP
Anu Lala, MD
Martha Gulati, MD, MS, FACC, FAHA
Proteinuria First: Managing What Matters in FSGS
KDIGO Conversations in NephrologyProteinuria First: Managing What Matters in FSGS
Kirk Campbell, MD
Laura H. Mariani, MD, MS,FASN
Nutrition as a Foundation for Long-Term Health
NutritionEdgeNutrition as a Foundation for Long-Term Health
Shelina Ramnarine, PhD
Jessica Clancy-Strawn, MA, RDN
The Podocyte Problem: Understanding FSGS
KDIGO Conversations in NephrologyThe Podocyte Problem: Understanding FSGS
Kirk Campbell, MD
Alessia Fornoni, MD, PhD
Treating FSGS: From Steroids to Dual Endothelin Angiotensin Receptor Antagonists and What Comes Next
NephrologyTreating FSGS: From Steroids to Dual Endothelin Angiotensin Receptor Antagonists and What Comes Next
Kirk Campbell, MD
Jai Radhakrishnan, MD
- advertisement
Hypertension Across Diverse Populations: Practical Strategies for Equitable Care
Heart MattersHypertension Across Diverse Populations: Practical Strategies for Equitable Care
Alexandria May, PharmD, BCPS
Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
Connecting Chronic Kidney Disease and Cardiovascular Risk in Primary Care
Heart MattersConnecting Chronic Kidney Disease and Cardiovascular Risk in Primary Care
Alexandria May, PharmD, BCPS
Javed Butler, MD, MPH, MBA
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
NephrologyOptimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Brendon Neuen, MBBS, PhD
